|
顯示項目 655276-655300 / 2310639 (共92426頁)
<< < 26207 26208 26209 26210 26211 26212 26213 26214 26215 26216 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2016-02-01 |
Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC).
|
Chiang, Nai-Jung; Tsai, Kelvin K.; Chen, Jen-Shi; Yang, Shih-Hung; Hsu, Chiun; Shan, Yan-Shen; Chen, Li-Tzong |
| 國立成功大學 |
2000 |
Phase I trial of weekly short infusion of single agent docetaxel in patients with advanced NSCLC/MBC.
|
Pan, Hsing-Ju; Tasi, Meng-Yi; Huang, Guang-Chang; Huang, Wen-Tsung; Chen, Tsai-Yun; Su, Wu-Chou; Taso, Chao-Jung |
| 國立成功大學 |
2014-11 |
Phase I, dose-escalation study of the investigational drug D07001-F4, an oral formulation of gemcitabine HCl, in patients (pts) with advanced solid tumors or lymphoma
|
Lin, C.; Su, W.; Lee, J.; Hsu, C.; Cheng, A.; Lin, C.; Ho, H.; Huang, C.; Hsueh, S.; Yang, J |
| 國立成功大學 |
2016-12 |
Phase I, dose-escalation study of the investigational drug D07001-F4, an oral formulation of gemcitabine HCl, in patients (pts) with advanced solid tumors or lymphoma
|
Lin, C. C.; Su, W. C.; Chao, Y.; Lee, J. H.; Hsu, C. H.; Cheng, A. L.; Chung, W. P.; Chen, M. H.; Lin, C. L.; Ho, H. L.; Huang, L. P.; Huang, C. T.; Hsueh, S. P.; Yang, J. C. H. |
| 國立臺灣大學 |
2016 |
Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumors
|
Minami, Hironobu; Ando, Yuichi; Ma, Brigette Buig Yue; Lee, Jih-Hsiang; Momota, Hiroyuki; Fujiwara, Yutaka; Li, Leung; Fukino, Koichi; Ito, Koji; Tajima, Takeshi; Mori, Asuka; Lin, Chia-Chi; 林家齊; 李日翔 |
| 臺大學術典藏 |
2020-05-25T07:35:17Z |
Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumors
|
Mori A; Tajima T; Ito K; Fukino K; Li L; Fujiwara Y; Momota H; Hsiang Lee J; Ma B.B.Y; Ando Y; Minami H; Chia-Chi Lin |
| 臺大學術典藏 |
2018-09-10T08:31:21Z |
Phase I, pharmacokinetic, and bone marrow drug-level studies of trimonthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers
|
Ho, Y.-F. Lu, W.-C. Chen, R.R.-L. Cheng, A.-L. Yeh, K.-H.; KUN-HUEI YEH; YUNN-FANG HO; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:09Z |
Phase I, pharmacokinetic, and bone marrow drug-level studies of trimonthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers
|
Ho Y.-F.; Lu W.-C.; Chen R.R.-L.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:42Z |
Phase I, pharmacokinetic, and bone marrow drug-level studies of trimonthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers
|
Ho Y.-F.;Lu W.-C.;Chen R.R.-L.;Cheng A.-L.;Kun-Huei Yeh; Ho Y.-F.; Lu W.-C.; Chen R.R.-L.; Cheng A.-L.; KUN-HUEI YEH |
| 國立臺灣大學 |
2009 |
Phase I, Pharmacokinetic, and Pharmacodynamic Study of Amg 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1
|
林家齊; LIN, CHIA-CHI |
| 國家衛生研究院 |
2006-03 |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah, HS; Cheng, AL; Hsu, C; Hsu, CH; Liu, TW; Chang, JY; Jan, CM; Chao, Y; Yu, WL; Chuang, TR; Whang-Peng, J; Chen, LT |
| 臺大學術典藏 |
2022-08-19T00:21:12Z |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah H.-S.; Cheng A.-L.; CHIUN HSU; Hsu C.-H.; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T. |
| 國立臺灣大學 |
2006 |
Phase I-Ii Trial of Weekly Gemcitabine Plus High-Dose 5-Fluorouracil and Leucovorin in Advanced Pancreatic Cancer
|
鄭安理; 許駿; 徐志宏; 劉滄梧; 張俊彥; 詹昌明; 趙毅; 尤維蘭; 彭汪嘉康; 陳立宗; CHENG, ANN-LII; HSU, CHIUN; HSU, CHIH-HUNG; LIU, TSANG-WU; CHANG, JANG-YANG; JAN, CHANG-MING; CHAO, YEE; YU, WEI-LAN; WHANG-PENG, JACQUELINE; CHEN, LI-TZONG |
| 臺大學術典藏 |
2020-04-10T12:51:26Z |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Chen L.-T.; Shiah H.-S.;Cheng A.-L.;Chiun Hsu;Hsu C.-H.;Liu T.-W.;Chang J.-Y.;Jan C.-M.;Chao Y.;Yu W.-L.;Chuang T.-R.;Whang-Peng J.;Chen L.-T.; Shiah H.-S.; Cheng A.-L.; Chiun Hsu; Hsu C.-H.; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J. |
| 臺大學術典藏 |
2020-04-28T07:25:35Z |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah H.-S.;Cheng A.-L.;Hsu C.;Chih-Hung Hsu;Liu T.-W.;Chang J.-Y.;Jan C.-M.;Chao Y.;Yu W.-L.;Chuang T.-R.;Whang-Peng J.;Chen L.-T.; Shiah H.-S.; Cheng A.-L.; Hsu C.; CHIH-HUNG HSU; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T02:02:13Z |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah H.-S.; ANN-LII CHENG; Hsu C.; Hsu C.-H.; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T. |
| 高雄醫學大學 |
2006 |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer.
|
鄭安理;林肇堂;詹昌明;彭汪嘉康;陳立宗 ; Shiah HS;Cheng AL;Hsu C;Hsu CH;Liu TW;Chang JY;Jan CM;Chao Y;Yu WL;Chuang TR;Whang-Peng J;Chen LT |
| 臺大學術典藏 |
2021-07-21T23:21:29Z |
Phase I/Ib clinical trial of sabatolimab, an anti–TIM-3 antibody, alone and in combination with spartalizumab, an anti–PD-1 antibody, in advanced solid tumors
|
Curigliano, Giuseppe; Gelderblom, Hans; Mach, Nicolas; Doi, Toshihiko; Tai, David; Forde, Patrick M.; Sarantopoulos, John; Bedard, Philippe L.; Chia-Chi Lin; Stephen Hodi, F.; Wilgenhof, Sofie; Santoro, Armando; Sabatos-Peyton, Catherine A.; Longmire, Tyler A.; Xyrafas, Alexandros; Sun, Haiying; Gutzwiller, Sabine; Manenti, Luigi; Naing, Aung |
| 臺大學術典藏 |
2022-09-15T01:08:48Z |
Phase I/Ib clinical trial of sabatolimab, an anti–TIM-3 antibody, alone and in combination with spartalizumab, an anti–PD-1 antibody, in advanced solid tumors
|
Curigliano G.; Gelderblom H.; Mach N.; Doi T.; Tai D.; Forde P.M.; Sarantopoulos J.; Bedard P.L.; Chia-Chi Lin; Stephen Hodi F.; Wilgenhof S.; Santoro A.; Sabatos-Peyton C.A.; Longmire T.A.; Xyrafas A.; Sun H.; Gutzwiller S.; Manenti L.; Naing A. |
| 國立臺灣大學 |
2008 |
Phase I/II study of a new autologous transplantation method for vitiligo treatment.
|
Chen, WYJ; Hong, JB; She, BR; Chan, CC; Chiu, HC; Lin, SJ |
| 國家衛生研究院 |
2008-05 |
Phase I/II study of capecitabine and PHY906 in hepatocellular carcinoma
|
Yen, Y;So, S;Rose, M;Saif, MW;Chu, E;Chen, L;Liu, S;Foo, A;Tilton, R;Cheng, Y |
| 臺大學術典藏 |
2020-05-25T07:35:09Z |
Phase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer
|
Chia-Chi Lin; Taylor M; Boni V; Brunsvig P.F; Geater S.L; Salvagni S; Garrido Lopez P; ?zg?ro?lu M; Sriuranpong V; Ponce Aix S; Ascierto P.A; Fasolo A; Sezer A; Kowalski D.M; Faris J.E; Cameron S; Mataraza J; Wu H; Antona V; Ochoa de Olza M. |
| 國立臺灣大學 |
2008 |
Phase I/Ii Trail of Cultured Autologous Melanocytes and a New Transplantation Method for Vitiligo Treatment
|
洪楨邦; 詹融怡; 邱顯清; 林頌然; HONG, JIN-BON; CHAN, JUNG-YI; CHIU, HSIEN-CHING; LIN, SUNG-JAN |
| 國立臺灣大學 |
2008 |
Phase I/II trail of cultured autologous melanocytes and a new transplantation method for vitiligo treatment.
|
Hong, JB; She, BR; Chan, CC; Chiu, HC; Lin, SJ |
| 國立成功大學 |
2020 |
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors
|
Desai, J.;Deva, S.;Lee, J.S.;Lin, C.-C.;Yen, C.-J.;Chao, Y.;Keam, B.;Jameson, M.;Hou, M.-M.;Kang, Y.-K.;Markman, B.;Lu, C.-H.;Rau, K.-M.;Lee, K.-H.;Horvath, L.;Friedlander, M.;Hill, A.;Sandhu, Sandhu S.;Barlow, P.;Wu, C.-Y.;Zhang, Y.;Liang, Liang L.;Wu, J.;Paton, V.;Millward, Millward M. |
顯示項目 655276-655300 / 2310639 (共92426頁)
<< < 26207 26208 26209 26210 26211 26212 26213 26214 26215 26216 > >>
每頁顯示[10|25|50]項目
|
